Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Transgene, AstraZeneca in exclusive license option deal for new oncolytic immunotherapies
May 2, 2019 Off

Transgene, AstraZeneca in exclusive license option deal for new oncolytic immunotherapies

By BusinessWire

Transgeen in agreement with AstraZeneca to co-developfive armed oncolytic vaccinia virus candidates. Innovative oncolyticviruses resulting from this collaboration will use Transgene’sproprietary next generation viral platform Invir.IO

May 2, 2019 Off

MindBytes BVBA Publishes First Peer-Reviewed Manuscript on Its SERES

By BusinessWire

TURNHOUT, Belgium & EDMONTON, Canada–(BUSINESS WIRE)–MindBytes BVBA and its subsidiary, MindLab Interactive AI Inc., (“MindBytes”) today announced that its first…

EDIT: Vivera Pharmaceuticals Licenses TABMELT, a Sublingual Pharmaceutical Drug-Delivery System for Cannabidiol (CBD)
May 2, 2019 Off

EDIT: Vivera Pharmaceuticals Licenses TABMELT, a Sublingual Pharmaceutical Drug-Delivery System for Cannabidiol (CBD)

By BusinessWire

Company to focus on benefits of CBD for non-addictive pain management and opioid, alcohol addiction recovery NEWPORT BEACH, Calif.–(BUSINESS WIRE)–lt;a…

Magenta Therapeutics Announces Pricing of Public Offering
May 2, 2019 Off

Magenta Therapeutics Announces Pricing of Public Offering

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of…

May 2, 2019 Off

Veeva, Cvent integrate Best-in-Class Events Management Capabilities

By BusinessWire

Industry leaders partner to help life sciences companies compliantlymanage global events

May 1, 2019 Off

vTv Therapeutics Announces 2019 First Quarter Financial Results and Update

By BusinessWire

HIGH POINT, N.C.–(BUSINESS WIRE)–vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the first quarter that ended March 31, 2019,…

May 1, 2019 Off

Lisa LaVange, PhD, Appointed to Board of Directors of Simulations Plus

By BusinessWire

Brings 35+ Years of Industry and Regulatory Expertise to Board LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq:SLP), the premier provider of…

May 1, 2019 Off

Multiple Surgeons to Present Data on Glaukos Technologies at 2019 American Society of Cataract and Refractive Surgery

By BusinessWire

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization…

May 1, 2019 Off

ICON Reports First Quarter 2019 Results

By BusinessWire

Highlights Net business wins (including pass-through) in the quarter of $885 million; a book to bill of 1.31. Closing backlog…

May 1, 2019 Off

Exelixis Initiating Phase 3 Pivotal Trial (COSMIC-313) of Cabozantinib in Combination with Nivolumab and Ipilimumab Versus Nivolumab and Ipilimumab in Previously Untreated Advanced Renal Cell Carcinoma

By BusinessWire

– COSMIC-313 is the third phase 3 pivotal trial to investigate cabozantinib in combination with immune checkpoint inhibitors – ALAMEDA,…

Posts pagination

Previous 1 … 3,234 3,235 3,236 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine